Premium
A multifaceted intervention to reduce inappropriate polypharmacy in primary care: research co‐creation opportunities in a pilot study
Author(s) -
Anderson Kristen,
Foster Michele M,
Freeman Christopher R,
Scott Ian A
Publication year - 2016
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja16.00125
Subject(s) - deprescribing , polypharmacy , co creation , context (archaeology) , stakeholder , co design , stakeholder engagement , intervention (counseling) , nursing , process management , process (computing) , medicine , business , knowledge management , public relations , computer science , political science , intensive care medicine , paleontology , computer architecture , biology , operating system
Summary Co‐creation (or co‐design) represents the highest form of stakeholder engagement, but it can be infeasible to co‐create with all stakeholders through all stages of a research project. The choice of stakeholders for co‐design will depend on the study purpose and context of change. For this deprescribing pilot study, general practitioners were recognised as a critical gateway for co‐creation, with patients' perspectives of the deprescribing process to be assessed in the evaluation of the pilot.